We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$33.8B
AUM Growth
+$4.19B
Cap. Flow
+$264M
Cap. Flow %
0.78%
Top 10 Hldgs %
21.76%
Holding
2,483
New
104
Increased
1,329
Reduced
987
Closed
53

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$52.4M
2
TSLA icon
Tesla
TSLA
+$42.1M
3
MSFT icon
Microsoft
MSFT
+$16.9M
4
DIS icon
Walt Disney
DIS
+$14.5M
5
MS icon
Morgan Stanley
MS
+$11.9M

Top Sells

Rank Stock Value
1
UN
Unilever NV New York Registry Shares
UN
+$48.8M
2
T icon
AT&T
T
+$25.4M
3
JNJ icon
Johnson & Johnson
JNJ
+$20M
4
AMZN icon
Amazon
AMZN
+$15.7M
5
BIIB icon
Biogen
BIIB
+$12.3M

Sector Composition

Rank Sector Weight
1 Technology 25.51%
2 Financials 13.6%
3 Healthcare 13.1%
4 Consumer Discretionary 11.54%
5 Communication Services 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HMY icon
2026
Harmony Gold Mining
HMY
$9.58B
$438K ﹤0.01%
93,682
+6,991
+8% +$34.5K
IBCP icon
2027
Independent Bank Corp
IBCP
$752M
$438K ﹤0.01%
23,712
+5,114
+27% +$83.8K
ALTA
2028
DELISTED
Altabancorp
ALTA
$438K ﹤0.01%
15,700
-182
-1% -$4.62K
OI icon
2029
O-I Glass
OI
$1.36B
$437K ﹤0.01%
36,736
-8,160
-18% -$93.1K
UIS icon
2030
Unisys
UIS
$256M
$437K ﹤0.01%
22,213
-722
-3% -$10.4K
DMC
2031
Del Monte Corp
DMC
$1.35B
$436K ﹤0.01%
18,116
-328
-2% -$7.91K
TVTX icon
2032
Travere Therapeutics
TVTX
$5.26B
$436K ﹤0.01%
15,981
+650
+4% +$15.2K
CRSP icon
2033
CRISPR Therapeutics
CRSP
$4.74B
$435K ﹤0.01%
+2,838
New +$335K
FTDR icon
2034
Frontdoor
FTDR
$5.14B
$432K ﹤0.01%
+8,603
New +$393K
ATRC icon
2035
AtriCure
ATRC
$1.75B
$431K ﹤0.01%
7,750
-2
-0% -$86
CTS icon
2036
CTS Corp
CTS
$1.75B
$429K ﹤0.01%
+12,498
New +$370K
BHE icon
2037
Benchmark Electronics
BHE
$3.04B
$428K ﹤0.01%
15,861
+2,765
+21% +$65.3K
NESR
2038
National Energy Services Reunited Corp
NESR
$2.87B
$426K ﹤0.01%
42,916
+140
+0.3% +$1.16K
INFN
2039
DELISTED
Infinera Corporation Common Stock
INFN
$426K ﹤0.01%
40,696
-669
-2% -$5.3K
MGP
2040
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$426K ﹤0.01%
13,612
+3,669
+37% +$109K
VSAT icon
2041
Viasat
VSAT
$10.1B
$421K ﹤0.01%
12,907
-633
-5% -$21.8K
TNET icon
2042
TriNet
TNET
$2.75B
$420K ﹤0.01%
5,215
-45
-0.9% -$3.33K
IBA
2043
DELISTED
Industrias Bachoco SAB De C.V.
IBA
$420K ﹤0.01%
9,294
+82
+0.9% +$3.34K
MYGN icon
2044
Myriad Genetics
MYGN
$558M
$417K ﹤0.01%
21,088
+770
+4% +$12.4K
GBT
2045
DELISTED
Global Blood Therapeutics, Inc.
GBT
$417K ﹤0.01%
9,629
+2,053
+27% +$101K
LOMA
2046
Loma Negra
LOMA
$1.34B
$416K ﹤0.01%
67,675
AEGN
2047
DELISTED
Aegion Corp
AEGN
$414K ﹤0.01%
21,789
+3,952
+22% +$66.2K
ADTN icon
2048
Adtran
ADTN
$983M
$413K ﹤0.01%
27,976
+1,185
+4% +$15K
HCI icon
2049
HCI Group
HCI
$2.28B
$412K ﹤0.01%
7,883
-1,906
-19% -$96.3K
LBRT icon
2050
Liberty Energy
LBRT
$4.06B
$412K ﹤0.01%
39,961
+1,392
+4% +$12.7K

Similar funds

Aperio Group's Q4 2020 Portfolio in Review

As of Q4 2020, Aperio Group held 2,483 positions worth $33.8B, up 14% from $29.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aperio Group's Q4 2020 filing shows 104 new, 1,329 increased, 987 reduced and 53 closed positions. Its largest new stake was Concentrix: 51,604 shares worth $5.09M. The largest sale was Unilever NV New York Registry Shares, an estimated $48.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2020 buy was Concentrix: 51,604 shares worth $5.09M.
  • Aperio Group added most to Unilever in Q4 2020, an estimated $52.4M increase.
  • Aperio Group's biggest Q4 2020 reduction was AT&T, cutting an estimated $25.4M.
  • Aperio Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $48.8M.
  • Aperio Group's ten largest holdings make up 22% of its $33.8B portfolio in Q4 2020.
  • Aperio Group opened 104 new positions and closed 53 in Q4 2020.
  • Aperio Group's portfolio value rose 14% quarter-over-quarter to $33.8B.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.